NO994138L - Rensing av von Willebrand-faktor ved kationebytterkromatografi - Google Patents

Rensing av von Willebrand-faktor ved kationebytterkromatografi

Info

Publication number
NO994138L
NO994138L NO994138A NO994138A NO994138L NO 994138 L NO994138 L NO 994138L NO 994138 A NO994138 A NO 994138A NO 994138 A NO994138 A NO 994138A NO 994138 L NO994138 L NO 994138L
Authority
NO
Norway
Prior art keywords
purification
cation exchange
exchange chromatography
von willebrand
willebrand factor
Prior art date
Application number
NO994138A
Other languages
English (en)
Other versions
NO994138D0 (no
NO324659B1 (no
Inventor
Bernhard Fischer
Iyvind L Schoenberger
Artur Mitterer
Christian Fiedler
Friedrich Dorner
Johann Eibl
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO994138D0 publication Critical patent/NO994138D0/no
Publication of NO994138L publication Critical patent/NO994138L/no
Publication of NO324659B1 publication Critical patent/NO324659B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Confectionery (AREA)
NO19994138A 1997-02-27 1999-08-26 Utvinning av von Willebrand-faktor ved kationebytterkromatografi samt preparat inneholdende slik faktor og anvendelse derav. NO324659B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0033797A AT405403B (de) 1997-02-27 1997-02-27 Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
PCT/AT1998/000034 WO1998038219A1 (de) 1997-02-27 1998-02-18 Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie

Publications (3)

Publication Number Publication Date
NO994138D0 NO994138D0 (no) 1999-08-26
NO994138L true NO994138L (no) 1999-08-26
NO324659B1 NO324659B1 (no) 2007-11-26

Family

ID=3487918

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994138A NO324659B1 (no) 1997-02-27 1999-08-26 Utvinning av von Willebrand-faktor ved kationebytterkromatografi samt preparat inneholdende slik faktor og anvendelse derav.

Country Status (11)

Country Link
US (1) US6465624B1 (no)
EP (1) EP1005492B1 (no)
JP (1) JP4250770B2 (no)
AT (2) AT405403B (no)
AU (1) AU737986B2 (no)
CA (1) CA2282843C (no)
DE (1) DE59813967D1 (no)
DK (1) DK1005492T3 (no)
ES (1) ES2285754T3 (no)
NO (1) NO324659B1 (no)
WO (1) WO1998038219A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
AT408443B (de) * 1998-02-27 2001-11-26 Immuno Ag Verfahren zur gewinnung von gereinigtem faktor viii:c/vwf-komplex
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
BRPI0514984A (pt) 2004-09-07 2008-07-01 Archemix Corp aptámeros para o fator de von willebrand e sua utilização como terapêuticos para doença trombótica
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
JP2008512097A (ja) * 2004-09-07 2008-04-24 アーケミックス コーポレイション アプタマー医薬品化学
DE102004044419B4 (de) 2004-09-14 2010-04-15 Biotest Ag Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie
DE102004044429B4 (de) 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
EP1835938B1 (en) 2004-12-27 2013-08-07 Baxter International Inc. Polymer-von willebrand factor-conjugates
US7683158B2 (en) 2006-03-31 2010-03-23 Baxter International Inc. Pegylated factor VIII
WO2008150495A2 (en) * 2007-06-01 2008-12-11 Archemix Corp. Vwf aptamer formulations and methods for use
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
EP3936116A1 (en) * 2007-12-28 2022-01-12 Takeda Pharmaceutical Company Limited Rrecombinant vwf containing formulations
PT2349314E (pt) * 2008-10-21 2013-05-28 Baxter Int Formulações de vwf recombinante liofilizado
AU2010284116B9 (en) * 2009-08-20 2015-03-26 Takeda Pharmaceutical Company Limited Purification of VWF for increased removal of non-lipid enveloped viruses
CA2821711C (en) 2010-12-15 2017-10-10 Baxter International Inc. Eluate collection using conductivity gradient
EP3858375B1 (en) * 2011-06-10 2024-03-20 Takeda Pharmaceutical Company Limited Treatment of coagulation disease by administration of recombinant vwf
WO2015188224A1 (en) 2014-06-13 2015-12-17 Csl Limited Improved production of recombinant von willebrand factor in a bioreactor
PT3648788T (pt) 2017-07-07 2024-08-23 Takeda Pharmaceuticals Co Tratamento de hemorragia gastrointestinal em pacientes com doença de von willebrand grave por administração de fvw recombinante
AU2019240135B2 (en) 2018-03-21 2024-10-03 Takeda Pharmaceutical Company Limited Separation of VWF and VWF propeptide by chromatographic methods
CA3161383A1 (en) 2019-12-10 2021-06-17 Vera OTT Method for manufacturing a fibrinogen preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US5006642A (en) 1987-06-29 1991-04-09 Rhone-Poulenc Rorer Pharmaceuticals Inc. Purification of von Willebrand Factor by affinity chromatography
FR2632309B1 (fr) 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3904354A1 (de) 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
NZ237244A (en) * 1990-03-02 1992-10-28 Bio Technology General Corp Cloning and production of human von willebrand factor analogues and compositions thereof
FR2673632A1 (fr) 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
CA2159044A1 (en) 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
AT401270B (de) 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
DE4435485C1 (de) 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
DE4435392B4 (de) 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
US5887152A (en) 1995-04-12 1999-03-23 Advanced Micro Devices, Inc. Load/store unit with multiple oldest outstanding instruction pointers for completing store and load/store miss instructions

Also Published As

Publication number Publication date
JP2001513088A (ja) 2001-08-28
EP1005492B1 (de) 2007-04-11
JP4250770B2 (ja) 2009-04-08
NO994138D0 (no) 1999-08-26
WO1998038219A1 (de) 1998-09-03
EP1005492A1 (de) 2000-06-07
AU737986B2 (en) 2001-09-06
CA2282843C (en) 2008-12-02
ES2285754T3 (es) 2007-11-16
DK1005492T3 (da) 2007-08-13
AT405403B (de) 1999-08-25
CA2282843A1 (en) 1998-09-03
ATE359301T1 (de) 2007-05-15
NO324659B1 (no) 2007-11-26
US6465624B1 (en) 2002-10-15
ATA33797A (de) 1998-12-15
AU5847098A (en) 1998-09-18
DE59813967D1 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
NO994138D0 (no) Rensing av von Willebrand-faktor ved kationebytterkromatografi
AU569129B2 (en) Factor viii:c purification
ATE76412T1 (de) Homogenes erythropoietin.
ATE73856T1 (de) Reinigung, herstellung und verwendung von tumor- nekrosisfaktoren.
DK1015587T3 (da) DcR3 polypeptid, en TNFR-homolog
DK0869134T3 (da) Fremgangsmåde til udvinding af vækstfaktorer fra mælk eller et mælkederivat
HRP20020480B1 (en) Process for the purification of pharmacologically active proteins through cationic exchange chromatography
AR010121A1 (es) MÉTODO DE RECUPERACIoN DE COMPLEJO DE FACTOR VIII/FACTOR DE VON WILLEWBRAND (COMPLEJO DE FACTOR VIII/VWF) MEDIANTE CROMATOGRAFíA DE INTERCAMBIO CATIoNICO.
NO901769L (no) Fremgangsmaate for rensing av protein.
EA200200893A1 (ru) Очищенный лг
ATE278705T1 (de) Verfahren zur reinigung von proteinen
DK0383645T3 (da) Fremgangsmåde til fremstilling af antihæmofilifaktor (FVIIIc) med meget høj renhed
ATE247131T1 (de) Verfahren zur reinigung einer rohen albuminwässerigen lösung
ATE168097T1 (de) Verfahren zur reinigung von mittleren olefinen
RU2006123543A (ru) Способ очистки интерферона бета
KR960014343A (ko) 활성형 인 과립구 콜로니 자극인자의 정제방법
DE3670485D1 (de) Verfahren zur herstellung von additionsverbindungen aus 1 mol dimerisiertem oder niedrig-oligodimerisiertem 4,4'-diisocyanatodiphenylmethan und 2 bis 3 mol 4,4'-diisocyanatodiphenylmethan, entsprechende additionsverbindungen und ihre verwendung zur polyurethanherstellung.
ATE82130T1 (de) Verfahren zum affinitaetschromatografischen reinigen von faktor xiii.
DK0408734T3 (da) Fremgangsmåde til rensning af streptokinaser
RU97110634A (ru) Способ получения рекомбинантного интерферона- гамма человека
KR900013072A (ko) 친화성 크로마토그래피법에 의한 소형 전기가오리의 효소인 아세틸콜린에스테라제의 정제방법
BE902576A (fr) Traitement des immondices en récupérant la totalité
RO91266A2 (ro) Compozitie de cauciuc rezistenta la acid clorhidric concentrat
RU97118540A (ru) Средство для лечения дерматозов

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAXALTA INCORPORATED, CH

MK1K Patent expired